课题基金 / 基金详情

The critical role of CD4+ Th cells in CD8+ CTL responses and anti-tumor immunity

The critical role of CD4+ Th cells in CD8+ CTL responses and anti-tumor immunity
CD4 Th 细胞在 CD8 CTL 反应和抗肿瘤免疫中的关键作用
批准号:
197120
负责人:
Sokke Umeshappa Channakeshava
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-11-01 至 2011-11-01

项目摘要

项目成果

Sokke Umeshappa Channakeshava的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the major medical breakthroughs in human history is the eradication of life threatening diseases such as smallpox and rinderpest (a cattle disease). This was made possible by efficient vaccine development, which allowed our immune system to precise
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spring 2024 CIHR-III New Investigator Forum "Connecting and Advancing: Dr. Umeshappa's Elevator Pitch"
  • 批准号:
    495261
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2023
  • 负责人:
    Sokke Umeshappa Channakeshava
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    459663
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2021
  • 负责人:
    Sokke Umeshappa Channakeshava
  • 依托单位:
Development of an antigen-specific nanomedicine for the treatment of primary biliary cirrhosis, a severe autoimmune disease of the liver
  • 批准号:
    297029
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $10.2万
  • 财政年份:
    2013
  • 负责人:
    Sokke Umeshappa Channakeshava
  • 依托单位:
Visualizing and killing metastasis in liver
  • 批准号:
    243252
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $3.28万
  • 财政年份:
    2011
  • 负责人:
    Sokke Umeshappa Channakeshava
  • 依托单位: